Follow this preprint
The Efficacy of IL-6 Inhibitor Tocilizumab in Reducing Severe COVID-19 Mortality: A Systematic Review
Avi Kaye, Robert Siegel
doi: https://doi.org/10.1101/2020.07.10.20150938
Now published in PeerJ doi: 10.7717/peerj.10322
Avi Kaye
1Stanford University undergraduate – Department of Human Biology
Robert Siegel
2Stanford University Professor – Departments of Microbiology & Immunology and Human Biology

Posted September 03, 2020.
The Efficacy of IL-6 Inhibitor Tocilizumab in Reducing Severe COVID-19 Mortality: A Systematic Review
Avi Kaye, Robert Siegel
medRxiv 2020.07.10.20150938; doi: https://doi.org/10.1101/2020.07.10.20150938
Now published in PeerJ doi: 10.7717/peerj.10322
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3063)
- Dermatology (259)
- Emergency Medicine (459)
- Epidemiology (12995)
- Forensic Medicine (13)
- Gastroenterology (856)
- Genetic and Genomic Medicine (4803)
- Geriatric Medicine (443)
- Health Economics (749)
- Health Informatics (3043)
- Health Policy (1099)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (496)
- Neurology (4576)
- Nursing (243)
- Nutrition (678)
- Oncology (2373)
- Ophthalmology (671)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1235)
- Primary Care Research (516)
- Public and Global Health (7159)
- Radiology and Imaging (1592)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (400)
- Surgery (507)
- Toxicology (64)
- Transplantation (218)
- Urology (188)